H‐A Schoon

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Development and comparison of in vivo and in vitro models for endometritis in cows and mares

Myxomatous Degeneration of the Canine Mitral Valve: From Gross Changes to Molecular Events

Insights into Serotonin Signaling Mechanisms Associated with Canine Degenerative Mitral Valve Disease

TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves

Defining Postpartum Uterine Disease and the Mechanisms of Infection and Immunity in the Female Reproductive Tract in Cattle1

Defining postpartum uterine disease in cattle

Alpha-smooth muscle actin and serotonin receptors 2A and 2B in dogs with myxomatous mitral valve disease

Making sense of equine uterine infections: The many faces of physical clearance

ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs

Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model

Bacterial Biofilm and its Role in the Pathogenesis of Disease

Comparative Transcriptomic Profiling and Gene Expression for Myxomatous Mitral Valve Disease in the Dog and Human

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Expression of Transforming Growth Factor-β1, -β2 and -β3 in Normal and Diseased Canine Mitral Valves

Histomorphological endometrial status and influence of oxytocin on the uterine drainage and pregnancy rate in mares

Endometrial biopsies as an ancillary aid in diagnosis and prognosis of subfertility in the mare